Surgical treatment of medication-related osteonecrosis of the jaw in patients with autoimmune diseases
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This retrospective, single-center study compares the factors influencing the surgical outcomes of medication-related osteonecrosis of the jaw (MRONJ) in patients with and without autoimmune diseases (AIDs). The total surgical success rate was 92% during the mean 2-year follow-up period, and treatment failure was observed in 8% of all patients without AID and 12% of patients with AIDs. Bisphosphonate duration and administration route (intravenous) were found to be risk factors of MRONJ. A careful treatment plan should be developed with a multidisciplinary team including a rheumatologist and a maxillofacial surgeon to avoid the use of drugs that may adversely affect treatment results when MRONJ occurs in patients with AIDs.
Abstract
This retrospective, single-center study compares the factors influencing the surgical outcomes of medication-related osteonecrosis of the jaw (MRONJ) in patients with and without autoimmune diseases (AIDs). The total surgical success rate was 92% during the mean 2-year follow-up period, and treatment failure was observed in 8% of all patients without AID and 12% of patients with AIDs. Bisphosphonate duration and administration route (intravenous) were found to be risk factors of MRONJ. A careful treatment plan should be developed with a multidisciplinary team including a rheumatologist and a maxillofacial surgeon to avoid the use of drugs that may adversely affect treatment results when MRONJ occurs in patients with AIDs.
참고문헌 (22)
- Marx RE, "Pamidronate(Aredia)and zoledronate(Zometa)induced avascular necrosis of the jaws : a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)[DOI]
- Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014update", J Oral Maxillofac Surg, 72, pp.1938~1956 (2014)[DOI]
- Alamanos Y, "Epidemiology of adult rheumatoid arthritis", Autoimmun Rev, 4, pp.130~136 (2005)[DOI]
- Santos C, "Osteonecrosis of the jaw, biphosphonates and rheumatoid arthritis", Med Clin(Barc), 130, pp.37~ (2008)[DOI]
- Hamburger J, "Orofacial manifestations in patients with inflammatory rheumatic diseases", Best Pract Res Clin Rheumatol, 30, pp.826~850 (2016)[DOI]
- Choi NR, "Surgical treatment of medication-related osteonecrosis of the jaw : a retrospective study", Int J Environ Res Public Health, 17, pp.8801~ (2020)[DOI]
- Hochberg MC, "Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus", Arthritis Rheum, 40, pp.1725~ (1997)[DOI]
- van den Hoogen F, "2013 classification criteria for systemic sclerosis : an American College of Rheumatology", European League against Rheumatism collaborative initiative, 2013, pp.65, 2737~2747
- Bohan A, "Polymyositis and dermatomyositis(first of two parts)", N Engl J Med, 292, pp.344~347 (1975)[DOI]
- Bohan A, "Polymyositis and dermatomyositis(second of two parts)", N Engl J Med, 292, pp.403~407 (1975)[DOI]
- Bennet RM, "Kelley’s textbook of rheumatology", pp.1381~1397 (2009), Elsevier
- Vitali C, "Classification criteria for Sjögren’s syndrome : a revised version of the European criteria proposed by the American-European Consensus Group", Ann Rheum Dis, 61, pp.554~558 (2002)[DOI]
- Kahn MF, "Systemic diseases", pp.545~556 (1991), Flammarion
- Park JM, "Recurrent osteomyelitis caused by bisphosphonate intake showed abnormal osteophytes lack of Harversian system", Korean J Oral Maxillofac Pathol, 33, pp.181~190 (2009)
- Barasch A, "Risk factors for osteonecrosis of the jaws : a case-control study from the CONDOR dental PBRN", J Dent Res, 90, pp.439~444 (2011)[DOI]
- Choi WS, "Medicationrelated osteonecrosis of the jaw : a preliminary retrospective study of 130 patients with multiple myeloma", Maxillofac Plast Reconstr Surg, 39, pp.1~ (2017)[DOI]
- King R, "Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab-a review", Oral Surg Oral Med Oral Pathol Oral Radiol, 127, pp.289~299 (2019)[DOI]
- Kim HJ, "Bisphosphonate-related osteonecrosis of the jaw in metastatic breast cancer patients : a review of 25 cases", Maxillofac Plast Reconstr Surg, 38, pp.6~ (2016)[DOI]
- Wazzan T, "Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw(MRONJ)in multiple myeloma patients-a retrospective case control study", Spec Care Dentist, 38, pp.356~361 (2018)[DOI]
- Ruggiero SL, "Bisphosphonate-related osteonecrosis of the jaw : background and guidelines for diagnosis, staging and management", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, pp.433~441 (2006)[DOI]
- Henien M, "Methotrexate-associated osteonecrosis of the jaw : a report of two cases", Oral Surg Oral Med Oral Pathol Oral Radiol, 124, pp.e283~e287 (2017)[DOI]
- Eguchi T, "The assessment of surgical and non-surgical treatment of stage II medication-related osteonecrosis of the jaw", Med Oral Patol Oral Cir Bucal, 22, pp.e788~e795 (2017)[DOI]